Is Buying Teligent, Inc. (TLGT) Here a Winning Strategy?

April 16, 2018 - By Nellie Frank

The stock of Teligent, Inc. (NASDAQ:TLGT) is a huge mover today! The stock increased 6.12% or $0.175 during the last trading session, reaching $3.035. About 391,237 shares traded. Teligent, Inc. (NASDAQ:TLGT) has declined 56.12% since April 16, 2017 and is downtrending. It has underperformed by 67.67% the S&P500.
The move comes after 6 months positive chart setup for the $162.36 million company. It was reported on Apr, 16 by We have $3.22 PT which if reached, will make NASDAQ:TLGT worth $9.74M more.

Teligent, Inc., a specialty generic pharmaceutical company, develops, formulates, makes, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company has market cap of $162.36 million. The firm sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It currently has negative earnings. It also develops, makes, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets.

Teligent, Inc. (NASDAQ:TLGT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.